[home]
[thesaurus]
Click Here to return To Results
The Efficacy of Azathiorpine in Relapsing-Remitting Multiple Sclerosis
Neurol 41:20-25, Goodkin,D.E.,et al, 1991
See this aricle in Pubmed
Article Abstract
We randomized 59 patients with relapsing-remitting multiple sclerosis to receive azathioprine(AZA)3.0 mg/kg daily or placebo in a double-masked therapeutic trial.Analysis of data for predetermined primary outcome measures demonstrated a significant difference favoring AZA for observed mean exacerbation rate after 2 years of therapy and time to deterioration in both Ambulation Index and Kurtzke Expanded Disability Status Scale score.This study confirms a modest therapeutic benefit for azathiorpine previously reported by other investigators.
Related Tags
(click to filter results - removes previous filter)
azathioprine
immunosuppressive agents
multiple sclerosis
multiple sclerosis,relapsing
multiple sclerosis,treatment of
treatment of neurologic disorder
Click Here to return To Results